Race
Visit number vs SpO2 Range/Position: 80-89% Supine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 15.1 | ± 27.5 | 5.8 | 0.0 | 221.0 | 2 | 318 |
Follow-up | 275 | 10.7 | ± 29.9 | 0.8 | 0.0 | 304.3 | 26 | 301 |
Treatment Arm vs SpO2 Range/Position: 80-89% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 15.1 | ± 27.5 | 5.8 | 0.0 | 221.0 | 2 | 318 |
HLSE | 106 | 12.7 | ± 16.3 | 6.3 | 0.0 | 68.1 | - | 106 |
HLSE-O | 105 | 17.0 | ± 29.3 | 6.0 | 0.0 | 221.0 | 1 | 106 |
HLSE-P | 105 | 15.8 | ± 34.0 | 5.2 | 0.0 | 220.3 | 1 | 106 |
Treatment Arm vs SpO2 Range/Position: 80-89% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 10.7 | ± 29.9 | 0.8 | 0.0 | 304.3 | 26 | 301 |
HLSE | 94 | 17.8 | ± 41.8 | 3.2 | 0.0 | 304.3 | 6 | 100 |
HLSE-O | 95 | 7.2 | ± 20.8 | 0.1 | 0.0 | 177.2 | 6 | 101 |
HLSE-P | 86 | 7.0 | ± 20.0 | 0.5 | 0.0 | 133.0 | 14 | 100 |
Age category vs SpO2 Range/Position: 80-89% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 15.1 | ± 27.5 | 5.8 | 0.0 | 221.0 | 2 | 318 |
45-54 years | 52 | 15.4 | ± 24.9 | 8.4 | 0.0 | 122.1 | 1 | 53 |
55-64 years | 139 | 15.5 | ± 29.9 | 5.8 | 0.0 | 221.0 | - | 139 |
65 years or older | 125 | 14.6 | ± 25.9 | 4.9 | 0.0 | 220.3 | 1 | 126 |
Age category vs SpO2 Range/Position: 80-89% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 10.7 | ± 29.9 | 0.8 | 0.0 | 304.3 | 25 | 300 |
45-54 years | 42 | 7.4 | ± 12.9 | 1.0 | 0.0 | 59.1 | 7 | 49 |
55-64 years | 117 | 9.7 | ± 24.3 | 0.5 | 0.0 | 179.2 | 10 | 127 |
65 years or older | 116 | 13.0 | ± 38.2 | 1.0 | 0.0 | 304.3 | 8 | 124 |
Gender vs SpO2 Range/Position: 80-89% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 15.1 | ± 27.5 | 5.8 | 0.0 | 221.0 | 2 | 318 |
Female | 84 | 17.7 | ± 31.9 | 5.9 | 0.0 | 221.0 | - | 84 |
Male | 232 | 14.2 | ± 25.7 | 5.8 | 0.0 | 220.3 | 2 | 234 |
Gender vs SpO2 Range/Position: 80-89% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 10.7 | ± 29.9 | 0.8 | 0.0 | 304.3 | 26 | 301 |
Female | 73 | 12.5 | ± 28.7 | 1.0 | 0.0 | 177.2 | 6 | 79 |
Male | 202 | 10.1 | ± 30.4 | 0.6 | 0.0 | 304.3 | 20 | 222 |
Race vs SpO2 Range/Position: 80-89% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 311 | 15.1 | ± 27.7 | 5.8 | 0.0 | 221.0 | 2 | 313 |
White | 251 | 16.0 | ± 29.1 | 6.2 | 0.0 | 221.0 | 1 | 252 |
Black | 41 | 12.5 | ± 23.9 | 3.4 | 0.0 | 122.1 | 1 | 42 |
Other | 19 | 8.6 | ± 10.4 | 2.1 | 0.0 | 32.5 | - | 19 |
Race vs SpO2 Range/Position: 80-89% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 271 | 10.9 | ± 30.1 | 0.8 | 0.0 | 304.3 | 25 | 296 |
White | 219 | 12.1 | ± 32.8 | 0.9 | 0.0 | 304.3 | 18 | 237 |
Black | 34 | 5.2 | ± 14.6 | 0.2 | 0.0 | 73.8 | 6 | 40 |
Other | 18 | 6.7 | ± 8.1 | 2.0 | 0.0 | 28.6 | 1 | 19 |